DK0983342T3 - Dyrkningsmedium med sojabönneekstrakt som aminosyrekilde og ingen proteinkomplekser af dyreoprindelse - Google Patents

Dyrkningsmedium med sojabönneekstrakt som aminosyrekilde og ingen proteinkomplekser af dyreoprindelse

Info

Publication number
DK0983342T3
DK0983342T3 DK98923023T DK98923023T DK0983342T3 DK 0983342 T3 DK0983342 T3 DK 0983342T3 DK 98923023 T DK98923023 T DK 98923023T DK 98923023 T DK98923023 T DK 98923023T DK 0983342 T3 DK0983342 T3 DK 0983342T3
Authority
DK
Denmark
Prior art keywords
animal
amino acid
culture medium
complexes
acid source
Prior art date
Application number
DK98923023T
Other languages
English (en)
Inventor
Roberto Olivieri
Maria Kontakou
Lucia Tagliaferri
Antonella Giglioli
Fabio Sabbatini
Rino Rappuoli
Original Assignee
Novartis Vaccines & Diagnostic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9710981.3A external-priority patent/GB9710981D0/en
Priority claimed from GBGB9806802.6A external-priority patent/GB9806802D0/en
Application filed by Novartis Vaccines & Diagnostic filed Critical Novartis Vaccines & Diagnostic
Application granted granted Critical
Publication of DK0983342T3 publication Critical patent/DK0983342T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/21—Haemophilus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK98923023T 1997-05-28 1998-05-28 Dyrkningsmedium med sojabönneekstrakt som aminosyrekilde og ingen proteinkomplekser af dyreoprindelse DK0983342T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9710981.3A GB9710981D0 (en) 1997-05-28 1997-05-28 Culture medium
GBGB9806802.6A GB9806802D0 (en) 1998-03-30 1998-03-30 Culture medium
PCT/IB1998/000938 WO1998054296A1 (en) 1997-05-28 1998-05-28 Culture medium with yeast or soy bean extract as aminoacid source and no protein complexes of animal origin

Publications (1)

Publication Number Publication Date
DK0983342T3 true DK0983342T3 (da) 2008-01-07

Family

ID=26311607

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98923023T DK0983342T3 (da) 1997-05-28 1998-05-28 Dyrkningsmedium med sojabönneekstrakt som aminosyrekilde og ingen proteinkomplekser af dyreoprindelse

Country Status (10)

Country Link
EP (4) EP0983342B1 (da)
JP (3) JP4173560B2 (da)
AT (2) ATE372376T1 (da)
AU (1) AU7545298A (da)
CY (2) CY1107812T1 (da)
DE (2) DE69838383T2 (da)
DK (1) DK0983342T3 (da)
ES (1) ES2293681T3 (da)
PT (2) PT983342E (da)
WO (1) WO1998054296A1 (da)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6475725B1 (en) 1997-06-20 2002-11-05 Baxter Aktiengesellschaft Recombinant cell clones having increased stability and methods of making and using the same
AT409379B (de) 1999-06-02 2002-07-25 Baxter Ag Medium zur protein- und serumfreien kultivierung von zellen
US6558926B1 (en) * 1999-07-16 2003-05-06 Massachusetts Institute Of Technology Method for production of tetanus toxin using media substantially free of animal products
EP1074612A1 (en) * 1999-08-04 2001-02-07 Pasteur Merieux Serums Et Vaccins Use of vegetal peptones for DNA vaccine production
EP2332581B1 (en) 2001-01-23 2015-07-01 Sanofi Pasteur Inc. Tri- or tetravalent meningococcal polysaccharide-CRM197 conjugate vaccine
GB0115176D0 (en) 2001-06-20 2001-08-15 Chiron Spa Capular polysaccharide solubilisation and combination vaccines
WO2004033623A2 (en) * 2002-05-16 2004-04-22 Aventis Pasteur, Inc. Animal component free meningococcal polysaccharide fermentation and seedbank development
AU2003249990B2 (en) 2002-07-09 2007-06-28 Takeda Pharmaceutical Company Limited Animal protein free media for cultivation of cells
US20040037869A1 (en) * 2002-08-16 2004-02-26 Douglas Cleverly Non-animal product containing veterinary formulations
US7452697B2 (en) 2003-09-25 2008-11-18 Allergan, Inc. Chromatographic method and system for purifying a botulinum toxin
US7160699B2 (en) 2003-09-25 2007-01-09 Allergan, Inc. Media for clostridium bacterium and processes for obtaining a clostridial toxin
US7148041B2 (en) 2003-09-25 2006-12-12 Allergan, Inc. Animal product free media and processes for obtaining a botulinum toxin
CN1898376A (zh) * 2003-12-03 2007-01-17 圣诺菲·帕斯图尔有限公司 用于微生物的冷冻保护剂
CA2546769A1 (en) * 2003-12-12 2005-06-23 Sanofi Pasteur Limited Production of diphtheria toxin
GB0408978D0 (en) * 2004-04-22 2004-05-26 Chiron Srl Meningococcal fermentation for preparing conjugate vaccines
WO2006042542A2 (en) * 2004-10-19 2006-04-27 Statens Serum Institut Production of tetanus, diphtheria, and pertussis toxins and toxoids using fermentation media containing no components of animal or soy origin
US20060094104A1 (en) 2004-10-29 2006-05-04 Leopold Grillberger Animal protein-free media for cultivation of cells
BRPI0508299A (pt) * 2005-03-03 2007-07-31 Allergan Inc sistema livre de produto animal e processo para purificação de uma toxina botulina
NL1029059C2 (nl) * 2005-05-17 2006-11-20 Noord Nl Oliemolen Holding B V Peptidenpreparaat voor het groeien en/of kweken van micro-organismen en/of cellen.
PL1869161T3 (pl) * 2005-10-11 2010-07-30 Probiotical Spa Sposób wytwarzania niealergizujących hodowli bakterii probiotycznych i ich zastosowanie
PT1974014T (pt) 2006-01-04 2017-05-26 Baxalta Inc Meios de cultura celulares livres de oligopeptídeos
ES2316146T3 (es) * 2006-07-07 2009-04-01 Alpro Nv Metodo para preparar un analogo de producto lacteo.
US8697154B2 (en) 2007-03-05 2014-04-15 Om Pharma Sa Bacterial extract for respiratory disorders and process for its preparation
FR2918671B1 (fr) 2007-07-10 2010-10-15 Sanofi Pasteur Milieu de culture d'haemophilus influenzae type b.
US8129139B2 (en) 2009-07-13 2012-03-06 Allergan, Inc. Process for obtaining botulinum neurotoxin
EP2275527A1 (en) 2009-07-17 2011-01-19 ActoGeniX NV Animal component-free culture medium for bacterial fermentation
DE102011118371B4 (de) 2011-11-11 2014-02-13 Novartis Ag Zur Impfung von Menschen geeignete Zusammensetzung, die ein Diphtherie-Toxoid umfasst, sowie Verfahren zu deren Herstellung
EP2592137A1 (en) * 2011-11-11 2013-05-15 Novartis AG Fermentation media free of animal-derived components for production of diphtheria toxoids suitable for human vaccine use
GB2495341B (en) * 2011-11-11 2013-09-18 Novartis Ag Fermentation methods and their products
DE102011122891B4 (de) 2011-11-11 2014-12-24 Novartis Ag Fermentationsmedium, das frei von tierischen Bestandteilen ist, zur Herstellung von Diphtherie-Toxoiden zur Verwendung bei der Impfung von Menschen
BR102012013110A2 (pt) 2012-05-31 2014-05-27 Cristalia Prod Quimicos Farm Meio de cultura para bactérias do gênero clostridium livre de componentes de origem animal e processo para produção de sobrenadante contendo uma ou mais proteases com atividade colagenolítica e gelatinolítica
CN104263678A (zh) * 2014-09-02 2015-01-07 成都欧林生物科技股份有限公司 一种白喉杆菌培养基及应用其制备白喉类毒素的方法
EP3783010A1 (en) 2015-05-06 2021-02-24 Wageningen Universiteit Method of culturing akkermansia
KR102069988B1 (ko) * 2015-11-17 2020-01-23 화이자 인코포레이티드 박테리아 세포 배양에서 폴리사카라이드를 생성하기 위한 배지 및 발효 방법
CN110741013B (zh) 2017-04-22 2023-08-08 生物E有限公司 用于高水平生产crm的改进方法
EP3906049A1 (en) * 2019-01-04 2021-11-10 Boehringer Ingelheim Animal Health USA Inc. Attenuated bordetella bronchiseptica strains, oral vaccines containing the attenuated strains, and methods of making & use thereof
CN112646747B (zh) * 2021-01-08 2024-03-15 苏州聚微生物科技有限公司 破伤风梭状芽孢杆菌培养基

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695624A (en) * 1984-05-10 1987-09-22 Merck & Co., Inc. Covalently-modified polyanionic bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers, and methods of preparing such polysaccharides and conjugates and of confirming covalency
GB8924438D0 (en) * 1989-10-31 1989-12-20 Hoffmann La Roche Vaccine composition
DD294502A5 (de) 1990-05-15 1991-10-02 Dessau Tornau Impfstoffwerk Verfahren zur herstellung eines sojahydrolysats fuer mikrobiologische zwecke
IT1251751B (it) * 1991-10-31 1995-05-23 Sclavo Ricerca S R L Metodo per la coltura di microrganismi dei generi helicobacter, campylobacter e arcobacter, utilizzando terreni di coltura contenenti ciclodestrine o metil-cellulosa o loro miscele
DE4220889A1 (de) * 1992-06-25 1994-02-24 Mueller Karl & Co Kg Reaktivierungsmischung für Starterkulturen zur Rohwurstherstellung
US5314822A (en) * 1992-10-15 1994-05-24 Merck & Co., Inc. Method of clonal growth of Streptococcus pneumoniae
PT624376E (pt) * 1993-05-13 2000-07-31 American Cyanamid Co Preparacao e utilizacoes de proteinas de membranas externas deficitarias em los de cocos gram-negativos
US5494808A (en) * 1994-09-15 1996-02-27 Merck & Co., Inc. Defined medium OMPC fermentation process
GB9422096D0 (en) * 1994-11-02 1994-12-21 Biocine Spa Combined meningitis vaccine
GB9422331D0 (en) * 1994-11-04 1994-12-21 Biocine Spa H. pylori fermentation process

Also Published As

Publication number Publication date
ATE488574T1 (de) 2010-12-15
JP2008200047A (ja) 2008-09-04
EP1849860B1 (en) 2010-11-17
PT1849860E (pt) 2011-02-23
WO1998054296A1 (en) 1998-12-03
EP2199382A2 (en) 2010-06-23
PT983342E (pt) 2007-12-13
EP1849860A2 (en) 2007-10-31
DE69838383T2 (de) 2008-06-05
ATE372376T1 (de) 2007-09-15
DE69838383D1 (de) 2007-10-18
EP2199382A3 (en) 2010-09-22
EP1849860A3 (en) 2008-04-02
EP0983342B1 (en) 2007-09-05
JP2002501387A (ja) 2002-01-15
DE69842010D1 (de) 2010-12-30
AU7545298A (en) 1998-12-30
JP2012005495A (ja) 2012-01-12
CY1111178T1 (el) 2015-06-11
EP2267113B1 (en) 2013-07-17
JP4173560B2 (ja) 2008-10-29
EP2267113A1 (en) 2010-12-29
CY1107812T1 (el) 2013-06-19
ES2293681T3 (es) 2008-03-16
EP0983342A1 (en) 2000-03-08

Similar Documents

Publication Publication Date Title
DK0983342T3 (da) Dyrkningsmedium med sojabönneekstrakt som aminosyrekilde og ingen proteinkomplekser af dyreoprindelse
HK1083635A1 (en) Animal protein free media for cultivation of cells
DE69332981D1 (de) Methoden zur herstellung löslicher, oligomerer proteine
NO20001052L (no) 1C, 15N, 2H merkede proteiner for NMR-strukturbestemmelser og deres fremstilling
DK1220893T3 (da) Medium til protein-fri og serum-fri dyrkning af celler
ATE490336T1 (de) Verfahren zur verbesserten isolierung rekombinant produzierter proteine
BR9906927A (pt) Proteìnas de neisseria meningitidis
WO2001005997A3 (en) Method for production of tetanus toxin using media substantially free of animal products
ATE542891T1 (de) Verfahren zur herstellung von biologischen produkten in protein-freier kultur
BRPI0418317A (pt) vacina de aumento de crescimento à base de epitopo de neutralização
DK0395532T3 (da) Isoleringsmedium til identifikation af Salmonella-bakterier
HUP0101081A2 (hu) Tápközeg és eljárás vírustenyésztésre és szaporításra
FI102544B1 (fi) Menetelmä E.coli-kannan valmistamiseksi
ES2164125T3 (es) Procedimiento para la preparacion de l-leucina.
DK364081A (da) D-n-carbamoyl-alfa-aminosyrer og fremgangsmaade til fremstilling heraf
EP1762609A3 (en) Serum-free medium for producing substances of interest
DK1242602T3 (da) Proteinekspressionssystemer for ikke-patogene kinetoplastidae
DK0759981T3 (da) Fremgangsmåde til dyrkning af bakterier, der producerer proteiner, som udtrykkes på en temperaturreguleret måde
ATE305515T1 (de) Nukleotidsequenzen kodierend fur proteine beteiligt an der biosynthese von l-serin, verbessertes verfahren zur mikrobiellen herstellung von l-serin sowie ein dazu geeigneter genetisch veranderter mikroorganismus
SE9403636D0 (sv) Vaccine preparation
NO994788L (no) Fremgangsmåte for fremstilling av heterolog protein
NL300073I1 (nl) Vaccin.
DK197091A (da) Fremgangsmaade til fremstilling af proteiner med fviii aktivitet og/eller fviii derivater